ReviewCurrent medicinal chemistry2025
Salvage Structures, Known as Iron Chelating Agents, Acquired from the Nature and Matured in the Labs.
Review in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iron, as an essential element, plays a crucial role in ensuring the proper functioning of all living organisms. While the appropriate level of iron for the optimal functioning of organisms cannot be disregarded, an excessive amount of this element can be detrimental and give rise to various issues. Nonetheless, the condition of iron accumulation is exceedingly uncommon in the majority of individuals due to the presence of biological autoregulation systems. However, in certain genetic disorders, such as β - thalassemia major, sickle cell anemia, and others, the nature of the diseases or treatment procedures can lead to an overload of iron. Furthermore, numerous studies have substantiated the role of iron in exacerbating conditions in some non-iron-dependent disorders, such as cardiovascular diseases, cancer, malaria, and microbial infections. For the past few decades, iron-chelating agents have been employed to enhance the quality of life for patients with iron accumulation conditions. This review attempts to express the importance of natural and artificial iron chelating agents, as well as the necessity of their extraction, production, and use in vital situations. It also provides a brief overview of the paths pursued by researchers in these fields to introduce suitable compounds as practical iron scavengers for entry into the pharmaceutical market.
Indexed as
Identifiers
40855809What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.